A Repeated Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

NCT00663936 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating Safety, Tolerability, and PK of Multiple Ascending Doses of GC021109 in Subjects With Mild to Moderate Alzheimer's Disease

NCT02386306 ·Status: COMPLETED ·Phase: PHASE1

A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease

NCT06619613 ·Status: RECRUITING ·Phase: PHASE1

Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease

NCT03625401 ·Status: UNKNOWN ·Phase: PHASE2

A Study Of Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's Disease

NCT01066481 ·Status: WITHDRAWN ·Phase: PHASE2

Safety and Efficacy of MT-4666

NCT01764243 ·Status: COMPLETED ·Phase: PHASE2

A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

NCT02094729 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers

NCT01702467 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)

NCT02079909 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease

NCT00359944 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease

NCT00459550 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).

NCT02695004 ·Status: COMPLETED ·Phase: PHASE1

Study of LM11A-31-BHS in Mild-moderate AD Patients

NCT03069014 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of SHR-1707 With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease

NCT05681819 ·Status: COMPLETED ·Phase: PHASE1

Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease

NCT03790982 ·Status: UNKNOWN ·Phase: PHASE2

Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease

NCT01539031 ·Status: COMPLETED ·Phase: PHASE3

A Study of NH280105 in Healthy Adult Participants

NCT06870058 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate in Vascular Cognitive Impairment Patients

NCT05050604 ·Status: UNKNOWN ·Phase: PHASE4

Multiple Ascending Dose Study of TC-5619 in Healthy Elderly Subjects and Subjects With Alzheimer's Disease

NCT01254448 ·Status: COMPLETED ·Phase: PHASE1

Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of Age

NCT02576639 ·Status: COMPLETED ·Phase: PHASE2

Safety Study of MT-4666 in Subjects With Alzheimer's Disease

NCT02327182 ·Status: TERMINATED ·Phase: PHASE3

Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)

NCT01466088 ·Status: COMPLETED ·Phase: PHASE2

Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease

NCT01569516 ·Status: UNKNOWN ·Phase: PHASE2

A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease

NCT00930059 ·Status: COMPLETED ·Phase: PHASE2

Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)

NCT03740178 ·Status: WITHDRAWN ·Phase: PHASE1